Showing 181 - 200 results of 382 for search '"kidney transplantation"', query time: 0.07s Refine Results
  1. 181
  2. 182

    Biochemical Characteristics of Bone Mineral Metabolism before and throughout the First Year after Kidney Transplantation, Persistent Hyperparathyroidism, and Risk Factors in a Latin Population by Lourdes Balcázar-Hernández, Guadalupe Vargas-Ortega, Baldomero González-Virla, Martha Cruz-López, Raúl Rodríguez-Gómez, Ramón Espinoza-Pérez, Carlos Cuevas-García, Victoria Mendoza-Zubieta

    Published 2020-01-01
    “…Bone mineral metabolism disease, which included persistent hyperparathyroidism, is common after successful kidney transplantation (KT) and is related with negative outcomes in kidney transplant recipients. …”
    Get full text
    Article
  3. 183
  4. 184

    Vascular Reconstructions in Living Unrelated Kidney Transplant Using Donor Ovarian Vein and Recipient Inferior Epigastric Artery with Simultaneous Enucleation of a Complex Cyst by Giuseppe Serena, Javier Gonzalez, Giselle Guerra, Mohamed Ammar Al Nuss, Maykel Valdes, Gaetano Ciancio

    Published 2019-01-01
    “…A 57-year-old male patient underwent a living unrelated kidney transplant. The living donor kidney was procured through a laparoscopic hand-assisted right donor nephrectomy. …”
    Get full text
    Article
  5. 185
  6. 186
  7. 187
  8. 188
  9. 189
  10. 190

    Comparison of Effect Sevoflurane-Based Anesthesia and Propofol-Based Anesthesia on the Early Postoperative Renal Function of Living Kidney Transplant Donors: A Randomized Controlled Trial by Cai J, Kang F, Han M, Huang X, Yan W, Wan F, Li J

    Published 2025-01-01
    “…The impact of anaesthetics on postoperative biomarkers of renal injury in living kidney transplant donors is not well understood.Patients and Methods: 70 transplant donors who underwent kidney extraction were randomly assigned to following two groups: sevoflurane (S group) and propofol (P group). …”
    Get full text
    Article
  11. 191

    Is Bigger Better? Living Donor Kidney Volume as Measured by the Donor CT Angiogram in Predicting Donor and Recipient eGFR after Living Donor Kidney Transplantation by Chaudhry Adeel Ebad, David Brennan, Julio Chevarria, Mohammad Bin Hussein, Donal Sexton, Douglas Mulholland, Ciaran Doyle, Patrick O’Kelly, Yvonne Williams, Ruth Dunne, Conall O’Seaghdha, Dilly Little, Martina Morrin, Peter J. Conlon

    Published 2021-01-01
    “…We measured kidney volume bilaterally in living kidney donors using CT angiography and assessed the association with the donor remaining kidney and recipient kidney (donated kidney) function at 1 year after kidney transplantation. Donor volume was categorized into tertiles based on lowest, middle, and highest volume. …”
    Get full text
    Article
  12. 192

    Absence of mTOR Inhibitor Effect on Hepatic Cyst Growth: A Case Report of a Kidney Transplant Recipient with Autosomal Dominant Polycystic Kidney Disease by L. Friedrich, F. Barbey, M. Pascual, J.-P. Venetz

    Published 2012-01-01
    “…We report the case of a patient with ADPKD who underwent deceased kidney transplantation because of an end-stage renal disease. …”
    Get full text
    Article
  13. 193
  14. 194

    De Novo Donor-Specific HLA Antibody Development and Peripheral CD4+CD25high Cells in Kidney Transplant Recipients: A Place for Interaction? by Josefina Alberu, Maria Inés Vargas-Rojas, Luis E. Morales-Buenrostro, Jose C. Crispin, Roxana Rodríguez-Romo, Norma O. Uribe-Uribe, Gabriel Carrasco, Diana Gómez-Martín, Jorge Alcocer-Varela

    Published 2012-01-01
    “…The aim of this study was to determine whether the abundance of regulatory T cells (Tregs) (CD4+CD25high) affects the de novo development of anti-HLA donor-specific antibodies (DSAs) in kidney transplant recipients (KTRs). Methods. Unsensitized (PRA ≤ 10%, no DSA) adult primary KTRs who received a living (83%) or deceased (17%) KT in our Institution during 2004/2005 were included. …”
    Get full text
    Article
  15. 195
  16. 196

    Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection among Kidney Transplant Recipients: A Large Single-Center Experience by Emily E. Zona, Mina L. Gibes, Asha S. Jain, Juan S. Danobeitia, Jacqueline Garonzik-Wang, Jeannina A. Smith, Didier A. Mandelbrot, Sandesh Parajuli

    Published 2024-01-01
    “…Background. Kidney transplant recipients (KTRs) are a vulnerable immunocompromised population at risk of severe COVID-19 disease and mortality after SARS-CoV-2 infection. …”
    Get full text
    Article
  17. 197
  18. 198

    Persistent Mortality Risk From Device-related Healthcare-associated Infection in Kidney Transplant Recipients Despite Multifaceted Interventions Action Calls for a Zero-tolerance Policy by Maria Bethânia Peruzzo, MD, Luana Oliveira Calegari, MSc, Renato Demarchi Foresto, MD, PhD, Helio Tedesco-Silva, MD, PhD, José Medina Pestana, MD, PhD, Lúcio Requião-Moura, MD, PhD

    Published 2025-02-01
    “…Although multifaceted control intervention actions (bundles) are highly effective in reducing the risk of device-related healthcare-associated infections (d-HAIs), no studies have explored their impact on the outcomes of kidney transplant recipients (KTRs) or the extent of risk reduction achievable through the bundle implementation. …”
    Get full text
    Article
  19. 199
  20. 200